This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Assessing Everolimus in Fist Line Treatment on Pat...
Clinical trial

Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer (POORTOR)

Read time: 1 mins
Last updated:25th Jun 2013
It is a an open label, multicentric, phase II study assessing the efficacy of everolimus (given per os) as a first line treatment in kidney cancer of bad prognosis. 90 patients will be included (anticipated). The treatment by everolimus will continue until progression, significant toxicity or withdraw of consent
Category Value
Study start date 2013-06-25

View full details